Bronstein, Gewirtz & Grossman LLC announces that investors Regeneron Pharmaceuticals, Inc. with significant losses have the opportunity to bring a class action lawsuit against Investing.com
New York, New York–(Newsfile Corp. – January 19, 2025) – Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Regeneron (NASDAQ:) Pharmaceuticals, Inc. ( “Regeneron” or the “Company”) (NASDAQ: REGN) and certain of its officers.
Class definition
This action seeks damages against the defendants for alleged violations of federal securities laws on behalf of all persons and entities that purchased or otherwise acquired Regeneron securities between November 2, 2023 and October 30, 2024, both dates inclusive ( “Class Period” ). Such investors are encouraged to join the case by visiting the company’s website: bgandg.com/REGN.
Details of the case
The complaint alleges that throughout the Class Period, the defendants misrepresented potential violations of the False Claims Act by failing to report millions of dollars in rebates given to drug distributors in the form of credit card reimbursements.
What’s next?
A class action lawsuit has already been filed. If you would like to review a copy of the complaint, you may visit the company’s website: bgandg.com/REGN or you may contact Peretz Bronstein, Esq. or his client relationship manager, Nathan Miller, of Bronstein, Gewirtz & Grossman, LLC at 332-239-2660. If you suffered a loss at Regeneron, you have until March 10, 2025 to request that the court appoint you as lead plaintiff. Your ability to participate in the recovery does not require you to be the lead plaintiff.
There is no cost to you
We represent investors in contingent fee class actions. This means that we will ask the court to reimburse us for out-of-pocket costs and attorneys’ fees, usually a percentage of the total recovery, only if we are successful.
Why Bronstein, Gewirtz & Grossman
Bronstein, Gewirtz & Grossman, LLC is a nationally recognized firm that represents investors in securities class actions and shareholder derivatives. Our company has recovered hundreds of millions of dollars for investors across the country.
Follow us for updates on LinkedIn, X, Facebook (NASDAQ 🙂 or Instagram.
Advertising of lawyers. Previous results do not guarantee similar results.
To view the original version of this press release, visit https://www.newsfilecorp.com/release/236512
